Skip to content
Evidence-Based & Medically Referenced

Treating Small Intestinal Bacterial Overgrowth with Biofilm Disruptors

By Bacterial Overgrowth Editorial Team Published Updated 6 min reading time
Treating Small Intestinal Bacterial Overgrowth with Biofilm Disruptors

In short: biofilmsBiofilm A protective slime layer that microbial communities build around themselves. It can shield them from antimicrobial treatment. are layers of microbes held together by a sticky matrix that makes them harder for antibiotics and the immune system to reach. They have been seen in the lower small intestine and colon of people with IBS, but their role in SIBO itself has barely been studied1. “Biofilm disruptors” such as N-acetylcysteine (NAC), enzyme blends, EDTA and bismuth thiols are widely used by SIBO practitioners alongside antimicrobials. The only SIBO study is a review of 13 patients’ records6, so their benefit is unproven.

This guide explains what biofilms are, what is known about them in the gut, and what the evidence shows for each type of biofilm disruptor. For the antimicrobials themselves, see our guides to antibiotics and herbal antimicrobials.

What is a biofilm?

A biofilm is a community of microbes that attach to a surface and surround themselves with a self-made matrix of sugars, proteins and DNA. Biofilms reduce the effectiveness of antibiotics and protect bacteria from the immune system, which may help an overgrowth persist1. Biofilms are best known from dental plaque, chronic wounds and infected medical implants.

Biofilms in the gut

The strongest evidence for gut biofilms comes from colonoscopy:

  • In a 2021 study of 1,426 people at two European endoscopy centers, yellow-green biofilm layers on the lining of the last part of the small intestine (ileum) and the right colon were seen in 57% of people with IBS and 34% of people with ulcerative colitis, compared with 6% of controls. Biofilms were linked to overgrowth of E. coli and Ruminococcus gnavus and to a build-up of bile acids, a possible cause of diarrhea3.
  • A 2024 follow-up study found that methane-producing archaeaArchaea Single-celled microorganisms that are distinct from bacteria. Methane-producing archaea (methanogens) are responsible for intestinal methanogen overgrowth. (Methanobrevibacter) influenced which kind of biofilm formed, and called for research on the link between biofilms and SIBO4.
  • In laboratory experiments, Methanobrevibacter smithii, the main methane producer in the human gut, can form biofilms5. This is one reason methane SIBO is thought to be harder to clear.

A 2024 review concludes that gut biofilms are hard to treat and that “effective therapies are yet to be developed”2. A 2025 SIBO review notes that biofilms may explain why many people relapse after treatment, but that research on biofilms in the small intestine is still limited1.

Types of biofilm disruptors

Agent How it is thought to work Best evidence
N-acetylcysteine (NAC) Breaks bonds in mucus and the biofilm matrix No clear benefit with antibiotics for H. pylori in two meta-analyses89
Enzyme blends Digest the sugars and proteins of the matrix Laboratory studies7; one small SIBO chart review6
EDTA Binds minerals that help hold the matrix together Only as part of an enzyme blend6
Bismuth thiols Bismuth combined with sulfur compounds Laboratory studies of wound bacteria10
Lactoferrin Milk protein that binds iron Laboratory studies13

N-acetylcysteine (NAC)

NAC is a mucus-thinning medicine that can break down the biofilm matrix in the laboratory. The best test of whether it helps antibiotics work in the gut comes from H. pylori, a stomach infection that forms biofilms. A 2019 Cochrane review of 8 randomized trials with 559 people could not tell whether adding NAC to antibiotics improved eradication; the evidence was of very low certainty8. A 2022 meta-analysis of 8 trials with 1,167 people found no significant benefit (76% vs. 72% eradication)9. NAC has not been tested in a SIBO trial.

Enzyme blends and EDTA

Enzyme blends contain enzymes that break down sugars (such as cellulase and beta-glucanase), protein-digesting enzymes such as serrapeptase, and sometimes lysozyme or EDTA, a compound that binds minerals. In a 2023 laboratory study funded by a supplement company, a blend of enzymes, NAC and plant extracts reduced established biofilms of Candida and Staphylococcus. Against Pseudomonas, low doses helped but higher doses increased the biofilm7.

Bismuth and bismuth thiols

Bismuth is used in H. pylori treatment, and SIBO practitioners use it for hydrogen sulfide SIBO. Bismuth thiols, bismuth combined with sulfur compounds, are promoted as biofilm disruptors11. In a 2011 laboratory study of biofilms from chronic wounds, the best of 13 bismuth thiols killed far more bacteria than conventional antibiotics, but results varied widely between preparations10. There are no human gut studies.

The common over-the-counter form, bismuth subsalicylate, contains salicylate, a relative of aspirin. Its label warns against use in children and teenagers recovering from chickenpox or flu-like illness because of the risk of Reye’s syndrome, and against use with an aspirin allergy, an ulcer or a bleeding problem. It can turn the stool and tongue black12.

Lactoferrin and plant extracts

Lactoferrin is an iron-binding protein from milk. Laboratory studies suggest it can prevent and break up biofilms, mainly studied in chronic wounds13. Oregano oil also affects biofilms in laboratory studies; see its guide for the evidence.

The SIBO evidence

The only study of biofilm disruptors in SIBO is a 2025 review of the records of 13 patients at one clinic, all of whom took an 8-week herbal antimicrobial protocol6:

  • 8 patients also took a biofilm disruptor: an enzyme-EDTA blend (6 patients) or NAC (2 patients). 5 took herbs alone.
  • Breath hydrogen fell more with the disruptor (by 31 vs. 11 ppmParts per million (ppm) The unit breath-test laboratories use to report the concentration of hydrogen, methane and hydrogen sulfide in a breath sample.), and so did methane (by 26 vs. 2 ppm).
  • SIBO clearance rates did not differ significantly between the groups, and no one in either group cleared methane overgrowth.
  • The lead author owns the company that made the supplements used.

The authors call for larger controlled studies6. Until those exist, biofilm disruptors are best seen as an experimental add-on, not a necessary part of SIBO treatment.

How practitioners use them

SIBO practitioners usually give biofilm disruptors alongside antimicrobials, taken away from meals, as in the 2025 chart review6. The chart review’s authors suggest adding an enzyme-EDTA disruptor when a first month of treatment has not helped, and starting it from the beginning for methane overgrowth6.

Talk to your doctor before starting them, especially if you take other medicines, are pregnant, or have a bleeding disorder or an allergy to aspirin.

Die-off and binders

Some people feel worse for a few days after starting antimicrobials, with bloating, tiredness or headache. SIBO practitioners call this “die-off” and attribute it to the immune system reacting to substances released by dying bacteria. They report that it typically starts on day 2 and lasts 1 to 3 days. Strategies they recommend include temporarily halving the dose and binders such as activated charcoal, taken 2 to 3 hours away from medicines and supplements14.

The term comes from the Jarisch-Herxheimer reaction, a short-lived reaction with fever, chills and muscle pain seen mainly during treatment for syphilis15. Die-off in SIBO has not been studied. New or worsening symptoms can also be side effects of treatment, so severe or lasting symptoms are a reason to contact your doctor rather than push through.

Common questions

Do I need a biofilm disruptor to treat SIBO?

No. Standard treatment with antibiotics, herbal antimicrobials or an elemental diet does not include them, and their benefit has not been shown in a controlled trial6.

Are biofilms the reason SIBO comes back?

Possibly, but this has not been shown1. Underlying causes such as slow gut movement are better established; see our guide to preventing relapse.

Is NAC safe?

NAC is a widely used medicine. In the H. pylori trials, gut side effects were not clearly more common than without it8.

Works Cited & Scientific References 15
▼
  1. Small intestinal bacterial and fungal overgrowth: health implications and management perspectives - Nutrients 2025 (PMC)
  2. Gastrointestinal biofilms: endoscopic detection, disease relevance, and therapeutic strategies - Gastroenterology 2024 (PubMed)
  3. Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis - Gastroenterology 2021 (PMC)
  4. Archaea influence composition of endoscopically visible ileocolonic biofilms - Gut Microbes 2024 (PMC)
  5. Biofilm formation of mucosa-associated methanoarchaeal strains - Front Microbiol 2014 (PMC)
  6. Biofilm disruption enhances antimicrobial therapy for small intestinal bacterial overgrowth and intestinal methanogen overgrowth - Cureus 2025 (PMC)
  7. Disruption of established bacterial and fungal biofilms by a blend of enzymes and botanical extracts - J Microbiol Biotechnol 2023 (PMC)
  8. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication - Cochrane Database Syst Rev 2019 (PubMed)
  9. The efficacy of adjuvant N-acetylcysteine for the eradication of H. pylori infections: a systematic review and meta-analysis of randomized clinical trials - Clin Res Hepatol Gastroenterol 2022 (PubMed)
  10. In vitro efficacy of bismuth thiols against biofilms formed by bacteria isolated from human chronic wounds - J Appl Microbiol 2011 (PubMed)
  11. Herbal antibiotics for SIBO - SIBOinfo
  12. Bismuth subsalicylate (Pepto-Bismol) drug facts label - DailyMed, US National Library of Medicine
  13. Lactoferrin: a bioinspired, anti-biofilm therapeutic - Biofouling 2013 (PMC)
  14. SIBO die-off symptoms: how long it lasts and what helps - SIBOinfo
  15. The Jarisch-Herxheimer reaction: revisited - Travel Med Infect Dis 2013 (PubMed)